Tan K K - OmicsDI

Show results for

Unknown (7883)
Proteomics (210)
Transcriptomics (193)
Genomics (69)
Metabolomics (27)
Models (1)
Genomic (1)
Multiomics (1)

Organisms

Homo sapiens (176)
Mus musculus (58)
Gallus gallus (7)
Canis lupus familiaris (6)
Drosophila melanogaster (6)
Escherichia coli (5)
Saccharomyces cerevisiae (3)
Rattus norvegicus (3)
Caenorhabditis elegans (2)
Danio rerio (2)
Oryza sativa (2)
Arabidopsis thaliana (2)
Klebsormidium nitens (1)
Pseudomonas phage PaP1 (1)
Dunaliella tertiolecta (1)
Junonia coenia (1)
Sinorhizobium fredii (1)
Porphyromonas gingivalis ATCC 33277 (1)
Helicobacter pylori 26695 (1)
Treponema denticola (1)
Columba livia (1)
Yersinia pestis (1)
Porphyromonas gingivalis (1)
Mycobacterium tuberculosis (1)
Populus tremula x Populus alba (1)
Hordeum vulgare subsp. vulgare (1)
Pseudomonas aeruginosa PAO1 (1)
Plasmodium falciparum (1)
Yersinia pestis biovar Microtus str. 91001 (1)
Manihot esculenta (1)

Organisms

Homo sapiens (1)

Repository

biostudies-arrayexpress (218)
pride (140)
EGA (45)
MassIVE (34)
iProX (30)
MetaboLights (27)
jPOST (5)
BioModels (1)
dbGaP (1)
geo (1)
PeptideAtlas (1)
ENA (1)

Tissue

Cell culture (30)
Brain (13)
Epithelial cell (6)
Testis (5)
Bone marrow (4)
Permanent cell line cell (3)
Fibroblast (3)
Plant cell (3)
Stem cell (3)
Neutrophil (2)
Blood (2)
Gastric adenocarcinoma cell (2)
Root (2)
Blood serum (2)
Blood cell (2)
Skin (2)
T cell (2)
Stomach (2)
Lung (2)
Blood plasma (2)
Leaf (2)
Macrophage (2)
Liver (2)
Others (1)
Fungal spore (1)
Fiber (1)
Colonic mucosa (1)
Thyroid nodule (1)
Cell in vitro (1)
Plasma cell (1)

Disease

Alzheimer's disease (3)
Colon cancer (3)
Plasmodium falciparum malaria (2)
Cervix carcinoma (2)
Brain cancer (2)
Disease free (2)
Bacterial infectious disease (1)
Inoculated with P. syringae pv. tomato strain DC3000 + avrRps4 (1)
Metastatic colorectal cancer (1)
Cancer (1)
Normal (1)
Global developmental delay (1)
Developmental and epileptic encephalopathy 9 (1)
Hepatitis B (1)
Polycythemia vera (1)
Osteogenesis imperfecta (1)
Proteus syndrome (1)
Open-angle glaucoma (1)
Thyroid cancer (1)
Stomach cancer (1)
Irritable bowel syndrome (1)
Brain glioblastoma multiforme (1)
Hepatocellular carcinoma (1)
Colorectal cancer (1)
Malaria (1)
Cachexia (1)
Malignant neoplasm of ovary (1)
Kidney cancer (1)
Huntington Disease (1)
Multiple myeloma (1)

Technology Type

Mass Spectrometry (140)
Shotgun proteomics (86)
Mass spectrometry (23)
Bottom-up proteomics (17)
Gel-based experiment (12)
Data-dependent acquisition (10)
Affinity purification coupled with mass spectrometry proteomics (8)
Data-independent acquisition (6)
Top-down proteomics (5)
SWATH MS (5)
NMR spectroscopy (3)
SRM/MRM (2)
Chemical cross-linking coupled with mass spectrometry proteomics (2)
Illumina HiSeq 2000, HiSeq X Ten, Illumina HiSeq 2500, ILLUMINA (1)
Illumina, Illumina 300 Duo V2 - Bead Studio (1)
Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
All-ion fragmentation (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (12)
Liquid Chromatography MS - positive - reverse phase (12)
Illumina NovaSeq 6000 (11)
LTQ Orbitrap Velos (11)
GC-MS (9)
GC MS (6)
Q Exactive (4)
Illumina HiSeq 2000 (3)
LTQ Orbitrap Elite (2)
Flow injection analysis MS - (2)
Direct infusion MS - positive (2)
Direct infusion MS - negative (2)
Bruker (2)
Liquid Chromatography MS - (2)
Zymo Research (1)
PAXgene tubes (1)
MA900, Sony (1)
10x Chromium Controller (1)
Qiagen (1)
GenePix 4000A [Axon Instruments] (1)
Axon- GenePix4000B (1)
Illumina MiSeq (1)
NextSeq 500 (1)
Agilent 7890A GC with 5975C inert XL MSD (1)
MicrOTOF-Q II (1)
TripleTOF 6600 (1)
6540 Q-TOF LC/MS (1)
Orbitrap Exploris 480 (1)
LTQ Orbitrap (1)
Orbitrap Fusion Lumos (1)

Publication Date

2013 (46)
2021 (38)
2014 (34)
2022 (33)
2015 (32)
2024 (28)
2023 (26)
2026 (24)
2025 (24)
2016 (24)
2011 (23)
2010 (22)
2012 (18)
2017 (15)
2018 (12)
2019 (11)
2008 (10)
2009 (7)
2020 (7)
2007 (6)
2004 (2)
2006 (1)
2005 (1)

UNIPROT ID/AC

P0A7L0 (1)
P0AG67 (1)
Q9Y336 (1)
Q9UN19 (1)
Q9UJM3 (1)
Q9NQ25 (1)
Q9HBA0 (1)
Q9H422 (1)
Q9H2X6 (1)
Q99708 (1)
Q96NY8-2 (1)
Q96NY8 (1)
Q96DU3 (1)
Q8WU20 (1)
Q8NHJ6-3 (1)
Q8NHJ6 (1)
Q8N5H7 (1)
Q8IX19 (1)
Q86Z02 (1)
Q7Z6J2 (1)
Q76L83 (1)
Q6T4R5 (1)
Q68D51 (1)
Q5TGY3 (1)
Q13291 (1)
P57739 (1)
P56597 (1)
P35318 (1)
P29034 (1)
P20963 (1)

ENSEMBL ID

ENSG00000170477 (1)

CHEBI ID

CHEBI:32816 (10)
CHEBI:17568 (10)
CHEBI:16919 (9)
CHEBI:16359 (9)
CHEBI:6650 (9)
CHEBI:17750 (9)
CHEBI:17368 (9)
CHEBI:16344 (8)
CHEBI:22653 (8)
CHEBI:30769 (8)
CHEBI:28300 (8)
CHEBI:15741 (8)
CHEBI:18132 (8)
CHEBI:17596 (8)
CHEBI:16335 (8)
CHEBI:18237 (7)
CHEBI:22660 (7)
CHEBI:48430 (7)
CHEBI:18101 (7)
CHEBI:18012 (7)
CHEBI:17748 (7)
CHEBI:16797 (7)
CHEBI:17310 (7)
CHEBI:15727 (7)
CHEBI:15354 (7)
CHEBI:30915 (7)
CHEBI:24813 (7)
CHEBI:16708 (7)
CHEBI:17351 (7)
CHEBI:28716 (7)

Metabolite Name

Creatine (6)
Proline (6)
UDP-glucose (5)
Hypoxanthine (5)
Guanine (5)
Uracil (5)
Asparagine (5)
Adenosine (5)
Inosine (5)
UDP-galactose (4)
5-hydroxylysine (4)
N6-methyladenosine (4)
N-acetylneuraminate (4)
Riboflavin (4)
Beta-alanine (4)
Uracil (4)
Thymidine (4)
2'-deoxyadenosine 5'-monophosphate (4)
Hypoxanthine (4)
Allantoin (4)
2'-deoxyinosine (4)
Choline (4)
N-acetylputrescine (4)
Glycine (4)
4-acetamidobutanoate (4)
N-acetylmethionine (4)
L-Tryptophan (4)
Carnitine (4)
Valine (4)
Leucine (4)

First Public Date

2015 (1)

Modelling Approach

Ordinary differential equation model (1)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (13)
Laboratory of RNA Processing and Decay, Institute of Biochemistry and Biophysics, Warsaw, Poland (3)
BCMP, Harvard Medical School, Boston, USA Cancer Biology, Dana-Farber Cancer Institute, Boston, USA (2)
Central South University (2)
The Bone Biology and Disease Laboratory, School of Biomedical Sciences, The University of Western Australia (2)
Cancer Science Institute of Singapore, National University of Singapore (2)
State Key Laboratory of Reproductive Medicine and Offspring Health， Nanjing Medical University, Nanjing, China. (2)
Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Adolfa Pawińskiego 5A, 02-106 Warsaw, Poland (2)
St. Jude Children’s Research Hospital (2)
St. Jude Children's Research Hospital (2)
westlake.edu.cn (2)
Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, USA (1)
Department of Medical Genetics, Cambridge Institute for Medical Research, The Keith Peters Building, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, United Kingdom (1)
Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (1)
Department: Department of Microbiology and Immunology Lab: Host and Pathogen Interactivity Lab Institute: National University of Singapore Country: Singapore (1)
Laboratory of Cancer Biology and Epigenetics, Department of Cell Biology and Genetics, Shantou University Medical College, Shantou, 515041, Guangdong, People’s Republic of China (1)
Director, Advanced Clinical Biosystems Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048 (1)
Bioprocess Engeneering, IVT, Otto-von-Guericke University, Magdeburg, Germany (1)
Max Planck Institute of Immunobiology and Epigenetics Freiburg, Germany (1)
Department of Bioinformatics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China (1)
Chinese Center for Disease Control and Prevention (1)
University of Melbourne, Melbourne, Australia (1)
The Center for Chemical Biology, Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China (1)
Senior Group Leader Malaria Biochemistry Laboratory Francis Crick Institute London NW1 1AT (1)
Microbial Genomic Laboratory Division of Biological and Environmental Sciences and Engineering, Level 4, 4326-WS10, Building 2, King Abdullah University of Science and Technology (KAUST), (1)
Zilkha Neurogenetic Institute, University of Southern California, Los Angeles, CA, USA (1)
Department of Immunology and Transfusion Medicine, Oslo University Hospital and Hybrid Technology Hub - Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo. P.O. Box 1110 Blindern 0317, Oslo, Norway. (1)
1. Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, 3052, Victoria, Australia and Department of Medical Biology, The University of Melbourne, Royal Parade, Parkville, 3052, Victoria, Australia (1)
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research, Singapore 138648, Singapore (1)
Northwest A&F University, College of Animal Science and Technology, Yangling,Shaanxi,China (1)

IsPrivate

False (1)

Modification

15.994915 (1)
2x(15)N labeled L-lysine (1)
4x(15)N labeled L-arginine (1)
57.021464 (1)
4-tetrahydrothiazine-3-carboxylic acid (1)

Study type

Transcription profiling by array (138)
RNA-seq of coding RNA (32)
ChIP-seq (16)
ChIP-chip by tiling array (4)
Methylation profiling by array (4)
Methylation profiling by high throughput sequencing (4)
Comparative genomic hybridization by array (3)
DNA-seq (3)
Transcription profiling by SAGE (2)
Unknown experiment type (2)
Genotyping by array (2)
Other (2)
ChIP-chip by array (1)
RNA-seq of coding RNA from single cells (1)
RNA-seq of total RNA (1)

Release Date

2025 (1092)
2022 (971)
2023 (954)
2024 (903)
2021 (843)
2020 (662)
2019 (455)
2018 (420)
2017 (346)
2016 (291)
2015 (236)
2014 (196)
2026 (173)
2013 (131)
2012 (109)
2011 (90)
2010 (78)
2009 (50)
2008 (46)
2007 (21)
2006 (11)
2005 (7)
2004 (6)
2003 (4)
2002 (2)
1999 (2)
2001 (1)
1998 (1)

Previous page
1 / 839
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 839
Next page

Sort by:

Relevance

Page size

Escherichia coli K-12: luxS mutant LW12 vs. wild type W3110

Transcripitonal profiling of Escherichia coli K-12 comparing luxS mutant LW12 with wild type W3110 One-condition experiment, luxS mutant LW12 vs. wild type W3110

ORGANISM(S): Escherichia coli

2010-11-11 | E-GEOD-20606 | biostudies-arrayexpress

Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression.

Not available

S-EPMC6466664 | biostudies-literature

TTC33 forms a complex with WDR61 and PHF5A to recruit factors relevant to genomic integrity 2/2

The functions of many human proteins remain unknown, highlighting major gaps in our understanding of cellular biology. TTC33 is an evolutionarily conserved tetratricopeptide repeat (TPR) protein expressed across human tissues, whose molecular role is not defined. Here we identify the TTC33 partners ...

ORGANISM(S): Homo sapiens (Human)

2026-07-13 | PXD043138 | Pride

Phf5a and ttc33 form a vertebrate-specific novel complex coined ttc33-associated network (tan) which together with ccdc97 regulate levels of mrnas that mediate neurotransmitter release Wdr61